Last $5.77 USD
Change Today -0.05 / -0.86%
Volume 2.4M
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael A. Narachi M.S., M.B.A.

Chief Executive Officer, President and Director, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 45 board members in 4 different organizations across 5 different industries.

See Board Relationships
55$3,526,837
As of Fiscal Year 2013

Background*

Mr. Michael A. Narachi, also known as Mike, M.S., M.B.A, has been the Chief Executive Officer and President for Orexigen Therapeutics, Inc. since March 2009. Mr. Narachi has more than 25 years of biotechnology and pharmaceutical experience in clinical development, commercialization, strategic business development and planning at Orexigen. He serves as the Chief Executive Officer, Chairman and President of REN Pharmaceuticals Inc. He served as an Officer and Vice President ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

Chairman
Chairman, Chairman of Compensation Committee and Member of Audit Committee
Chairman, Chief Executive Officer and President
2006-2014
Former Director, Member of Transaction Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
2009-Present
Chief Executive Officer, President and Director

Education*

MA 1984
University of California
BS 1984
University of California
MBA
UCLA Anderson School of Management

Other Affiliations*

Annual Compensation*

Salary$625,000
Total Annual Compensation$625,000

Stock Options*

All Other Compensation$7,926
Exercisable Options2,512,774
Unexercisable Options2,478,026
Total Number of Options4,990,800

Total Compensation*

Total Annual Cash Compensation$1,148,551
Total Short Term Compensation$625,000
Other Long Term Compensation$7,926
Total Calculated Compensation$3,526,837
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $5.77 USD -0.05

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.